A unified energy field theory of physiology and healing

Stress Medicine

Volumn 13, Issue 4, 1997, Pages 259-265

  Wisneski, Leonard A ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NONE   (United States)

Author keywords

Chi (also spelled qi); Endocrine; Energy field; Melatonin; Pineal; Prana; Psychoneuroimmunology

Indexed keywords

ANANDAMIDE; BENZODIAZEPINE RECEPTOR; BETA ENDORPHIN; HORMONE; MELATONIN; PEPTIDE;

ALPHA RHYTHM; ARTICLE; BIOENERGY; CHINESE MEDICINE; ENDOCRINE GLAND; HEALING; HUMAN; PINEAL BODY; PSYCHOPHYSIOLOGY; THETA RHYTHM;

EID: 0030725617     PISSN: 07488386     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1700(199710)13:4<259::AID-SMI756>3.0.CO;2-W     Document Type: Article

References (29)

1. Fahrion, S. L., Wirkus, M. and Pooley, P. EEG amplitude, brain mapping, and synchrony in and between a bioenergy practitioner and client during healing. Subtle Energies 1992; 3: 19-52.
2. Wirkus Bioenergy Foundation. Bioenergy, A Healing Art. Bethesda, Maryland, 1992. Videotape.
3. Rosch, P. Future directions in psychoneuro-immunology: Psychoelectroneuroimmunology? In: Stress, the Immune System and Psychiatry. Leonard, E. and Miller, K. (Eds) Wiley, Chichester, 1995.
4. DeFabo, E. C. and Noonan, F. P. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J. Exp. Med. 1983; 158: 84-98.
5. Fisher, M. S. and Kripke, M. L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc. Nat. Acad. Sci. USA 1977; 74: 1688-1692.
6. Epstein, J. H. Photocarcinogenesis, a review. Nat. Cancer Inst. Monogr. 1978; 50: 13-25.
7. Forbes, P. D., Davies, R. E. and Urbach, F. Experimental ultraviolet photocarcinogenesis: wavelength interactions and time-dose relationships. Nat. Cancer Inst. Monogr. 1978; 50: 31-38.
8. Adey, W. R. Electromagnetic fields, cell membrane amplification, and cancer promotion. In: Extremely Low Frequency Magnetic Fields: The Question of Cancer. Wilson, B. W., Stevens, R. G. and Anderson, L. E. (Eds) Battelle Press, Columbus, Ohio, 1990, pp. 211-249.
9. Lin, R. S., Dischinger, P. C., Conde, J. and Farrell, K. P. Occupational exposure to electromagnetic fields and the occurrence of brain tumors: An analysis of possible associations. J. Occup. Med. 1985; 27: 413-419.
10. Loomis, D. P., Savitz, D. A. and Ananth, C. V. Breast cancer mortality among female electrical workers in the United States. J. Nat. Cancer Inst. 1994; 86: 921-925.
11. Matanoski, G. M., Breysse, P. N. and Elliot, E. A. Electromagnetic field exposure and male breast cancer. Lancet 1991; 337: 737-738.
12. Savitz, D. A., Wachtel, H., Barnes, F., John, E. M. and Tvrdik, J. G. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am. J. Epidemiol. 1988; 128: 21-38.
13. Stevens, R. G. Electric power use and breast cancer: A hypothesis. Am. J. Epidemiol. 1987; 125: 556-561.
14. Davidson, J. Subtle Energy. C. W. Daniel Company, Essex, 1987.
15. Narayan, P. V. S. Magnetic environment of man. In: Energy Medicine Around the World. Srinivasan, T. M. (Ed.) Gabriel Press, Phoenix, Arizona, 1988, pp. 175-190.
16. Devane, W. A., Hanus, L., Breuer, A. et al. Isolation and structure of a brain constituent that binds to the cannibinoid receptor. Science 1992; 258: 1946-1949.
17. Mechoulam, R., Hanus, L. and Martin, B. R. Search for endogenous ligands of the cannabinoid receptor. Biochem. Pharmacol. 1994; 48: 1537-1544.
18. Felder, C. C., Nielsen, A., Briley, E. M. et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996; 393: 231-235.
19. Marangos, P. J., Patel, J., Hirata, F. et al. Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxy kynurenamine. Life Sci. 1981; 29: 259-267.
20. Caroleo, M. C., Frasca, D., Nistico, G. and Doria, G. Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 1992; 23:81-89.
21. Guerrerro, J. M. and Reiter, R. J. A brief survey of pineal gland-immune system interrelationships. Endocr. Res. 1992; 18: 91-113.
22. Reiter, R. J. Antioxidant actions of melatonin. Adv. Pharmacol. 1997; 38: 103-117.
23. Leach, C. M. and Thorburn, G. D. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins 1980; 20: 51-56.
24. Cardinali, D. P., Del Zar, M. M. and Vacas, M. I. The effects of melatonin in human platelets. Acta Physiol. Pharmacol. Ther. Latinoam. 1993; 43: 1-13.
25. Binkley, S. The Pineal, Endocrine and Nonendocrine Function. Prentice Hall, Englewood Cliffs, New Jersey, 1988.
26. Vaughn, M. K. Pineal peptides: An overview. In: The Pineal Gland. Reiter, R. J. (Ed.) Raven Press, New York, 1984, pp. 39-81.
27. Miguez, J. M., Simmonneauz, V. and Pevet, P. Evidence for a regulatory role of melatonin on serotonin release and uptake in the pineal gland. J. Neuroendocrinol. 1995; 7: 949-956.
28. Lewy, A. J. Biochemistry and regulation of mammalian melatonin production. In: The Pineal Gland. Relkin, R. (Ed.) Elsevier Biomedical, New York, 1983, pp. 77-128.
29. William, R. The Complete Illustrated Guide to Chinese Medicine. Element Books, Shaftesbury, 1996.